M. L. Ancelin and K. Ritchie, Lifelong Endocrine Fluctuations and Related Cognitive Disorders, Current Pharmaceutical Design, vol.11, issue.32, pp.4229-4252, 2005.
DOI : 10.2174/138161205774913228
URL : https://hal.archives-ouvertes.fr/inserm-00243083

G. L. Anderson, Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial, The Journal of the American Medical Association, vol.291, pp.1701-1712, 2004.

C. Behl, Oestrogen as a neuroprotective hormone, Nature Reviews Neuroscience, vol.3, pp.433-442, 2002.

M. L. Brandi, Association of the Estrogen Receptor ?? Gene Polymorphisms with Sporadic Alzheimer's Disease, Biochemical and Biophysical Research Communications, vol.265, issue.2, pp.335-338, 1999.
DOI : 10.1006/bbrc.1999.1665

T. Den-heijer, Variations in estrogen receptor ?? gene and risk of dementia, and brain volumes on MRI, Molecular Psychiatry, vol.9, issue.12, pp.1129-1135, 2004.
DOI : 10.1038/sj.mp.4001553

J. Dunkin, Reproductive events modify the effects of estrogen replacement therapy on cognition in healthy postmenopausal women, Psychoneuroendocrinology, vol.30, issue.3, pp.284-296, 2005.
DOI : 10.1016/j.psyneuen.2004.09.002

M. A. Espeland, Conjugated Equine Estrogens and Global Cognitive Function in Postmenopausal Women<SUBTITLE>Women's Health Initiative Memory Study</SUBTITLE>, JAMA, vol.291, issue.24, pp.2959-2968, 2004.
DOI : 10.1001/jama.291.24.2959

B. Ettinger, E. Barrett-connor, L. A. Hoq, J. P. Vader, and R. W. Dubois, When is it appropriate to prescribe postmenopausal hormone therapy? Menopause, pp.404-410, 2006.

C. M. Farquhar, J. Marjoribanks, A. Lethaby, Q. Lamberts, and J. A. Suckling, Long term hormone therapy for perimenopausal and postmenopausal women, Cochrane Database of Systematic Reviews, p.4143, 2005.

C. Forsell, Investigations of a CA repeat in the oestrogen receptor ?? gene in patients with Alzheimer's disease, European Journal of Human Genetics, vol.9, issue.10, pp.802-804, 2001.
DOI : 10.1038/sj.ejhg.5200714

S. Gao, H. C. Hendrie, K. S. Hall, and S. Hui, The Relationships Between Age, Sex, and the Incidence of Dementia and Alzheimer Disease, Archives of General Psychiatry, vol.55, issue.9, pp.809-815, 1998.
DOI : 10.1001/archpsyc.55.9.809

S. M. Harman, KEEPS: The Kronos Early Estrogen Prevention Study, Climacteric, vol.135, issue.1, pp.3-12, 2005.
DOI : 10.1001/jama.289.20.2663

E. Hogervorst, J. Williams, M. Budge, W. Riedel, and J. Jolles, The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis, Neuroscience, vol.101, issue.3, 2000.
DOI : 10.1016/S0306-4522(00)00410-3

E. Hogervorst, K. Yaffe, M. Richards, and F. Huppert, Hormone replacement therapy for cognitive function in postmenopausal women, Cochrane Database of Systematic Reviews, vol.356, issue.1, p.31, 2002.
DOI : 10.1002/14651858.CD003122

E. Hogervorst, K. Yaffe, M. Richards, and F. Huppert, Hormone replacement therapy to maintain cognitive function in women with dementia (Cochrane Review) Cochrane Database of Systematic Reviews, p.37, 2002.

K. Isoe-wada, Positive association between an estrogen receptor gene polymorphism and Parkinson's disease with dementia, European Journal of Neurology, vol.42, issue.1, pp.431-435, 1999.
DOI : 10.1016/S0006-8993(97)00330-2

Y. Ji, K. Urakami, K. Wada-isoe, Y. Adachi, and K. Nakashima, Estrogen Receptor Gene Polymorphisms in Patients with Alzheimer???s Disease, Vascular Dementia and Alcohol-Associated Dementia, Dementia and Geriatric Cognitive Disorders, vol.11, issue.3, pp.119-122, 2000.
DOI : 10.1159/000017224

H. S. Kok, Cognitive function across the life course and the menopausal transition in a British birth cohort, Menopause, vol.13, issue.1, pp.19-27, 2006.
DOI : 10.1097/01.gme.0000196592.36711.a0

H. M. Kravitz, P. M. Meyer, T. E. Seeman, G. A. Greendale, and M. R. Sowers, Cognitive Functioning and Sex Steroid Hormone Gene Polymorphisms in Women at Midlife, The American Journal of Medicine, vol.119, issue.9, pp.94-102, 2006.
DOI : 10.1016/j.amjmed.2006.07.030

J. C. Lambert, Are the estrogen receptors involved in Alzheimer's disease?, Neuroscience Letters, vol.306, issue.3, pp.193-197, 2001.
DOI : 10.1016/S0304-3940(01)01806-7

E. S. Leblanc, J. Janowsky, B. K. Chan, and H. D. Nelson, Hormone Replacement Therapy and Cognition, JAMA, vol.285, issue.11, pp.1489-1499, 2001.
DOI : 10.1001/jama.285.11.1489

A. H. Maclennan, Hormone therapy, timing of initiation, and cognition in women aged older than 60 years: the REMEMBER pilot study, Menopause, vol.13, issue.1, pp.28-36, 2006.
DOI : 10.1097/01.gme.0000191204.38664.61

P. Maki and E. Hogervorst, HRT and cognitive decline, Best Practice & Research Clinical Endocrinology & Metabolism, vol.17, issue.1, pp.105-122, 2003.
DOI : 10.1016/S1521-690X(02)00082-9

J. Marx, Searching for drugs that combat Alzheimer's. Science, pp.50-53, 1996.

L. Olsen, Estrogen receptor alpha and risk for cognitive impairment in postmenopausal women, Psychiatric Genetics, vol.16, issue.2, pp.85-88, 2006.
DOI : 10.1097/01.ypg.0000194445.27555.71

M. Pirskanen, Estrogen receptor beta gene variants are associated with increased risk of Alzheimer's disease in women, European Journal of Human Genetics, vol.322, issue.9, pp.1000-1006, 2005.
DOI : 10.1038/sj.ejhg.5201447

S. R. Rapp, Effect of Estrogen Plus Progestin on Global Cognitive Function in Postmenopausal Women, JAMA, vol.289, issue.20, pp.2663-2672, 2003.
DOI : 10.1001/jama.289.20.2663

N. L. Rasgon, Endogenous and exogenous hormone exposure and risk of cognitive impairment in Swedish twins: a preliminary study, Psychoneuroendocrinology, vol.30, issue.6, pp.558-567, 2005.
DOI : 10.1016/j.psyneuen.2005.01.004

S. M. Resnick, Effects of Combination Estrogen Plus Progestin Hormone Treatment on Cognition and Affect, The Journal of Clinical Endocrinology & Metabolism, vol.91, issue.5, pp.1802-1810, 2006.
DOI : 10.1210/jc.2005-2097

A. S. Rigaud, G. Andre, B. Vellas, J. Touchon, and J. J. Pere, No additional benefit of HRT on response to rivastigmine in menopausal women with AD, Neurology, vol.60, issue.1, pp.148-149, 2003.
DOI : 10.1212/WNL.60.1.148-a

K. Ritchie, Prevalence of DSM--IV psychiatric disorder in the French elderly population, The British Journal of Psychiatry, vol.184, issue.2, pp.147-152, 2004.
DOI : 10.1192/bjp.184.2.147

J. Rymer, R. Wilson, and K. Ballard, Making decisions about hormone replacement therapy, BMJ, vol.326, issue.7384, pp.322-326, 2003.
DOI : 10.1136/bmj.326.7384.322
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1125186

L. S. Schneider, M. R. Farlow, V. W. Henderson, and J. M. Pogoda, Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease, Neurology, vol.46, issue.6, pp.1580-1584, 1996.
DOI : 10.1212/WNL.46.6.1580

S. A. Shumaker, Conjugated Equine Estrogens and Incidence of Probable Dementia and Mild Cognitive Impairment in Postmenopausal Women<SUBTITLE>Women's Health Initiative Memory Study</SUBTITLE>, JAMA, vol.291, issue.24, pp.2947-2958, 2004.
DOI : 10.1001/jama.291.24.2947

S. A. Shumaker, Estrogen Plus Progestin and the Incidence of Dementia and Mild Cognitive Impairment in Postmenopausal Women, JAMA, vol.289, issue.20, pp.2651-2662, 2003.
DOI : 10.1001/jama.289.20.2651

S. O. Skouby, Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy, Maturitas, vol.51, issue.1, pp.8-14, 2005.
DOI : 10.1016/j.maturitas.2005.02.019

K. Urakami, Causative Genes in Alzheimer's Disease., Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics, vol.38, issue.2, pp.117-120, 2001.
DOI : 10.3143/geriatrics.38.117

C. Usui, No Genetic Association between the Myeloperoxidase Gene ???463 Polymorphism and Estrogen Receptor-?? Gene Polymorphisms and Japanese Sporadic Alzheimer???s Disease, Dementia and Geriatric Cognitive Disorders, vol.21, issue.5-6, pp.296-299, 2006.
DOI : 10.1159/000091437

A. Wimo, B. Winblad, H. Aguero-torres, V. Strauss, and E. , The Magnitude of Dementia Occurrence in the World, Alzheimer Disease & Associated Disorders, vol.17, issue.2, pp.63-67, 2003.
DOI : 10.1097/00002093-200304000-00002

K. Yaffe, L. Y. Lui, D. Grady, K. Stone, and P. Morin, Estrogen receptor 1 polymorphisms and risk of cognitive impairment in older women, Biological Psychiatry, vol.51, issue.8, pp.677-682, 2002.
DOI : 10.1016/S0006-3223(01)01289-6

K. Yaffe, G. Sawaya, I. Lieberburg, and D. Grady, Estrogen Therapy in Postmenopausal Women, JAMA, vol.279, issue.9, pp.688-695, 1998.
DOI : 10.1001/jama.279.9.688

P. P. Zandi, Hormone Replacement Therapy and Incidence of Alzheimer Disease in Older Women<SUBTITLE>The Cache County Study</SUBTITLE>, JAMA, vol.288, issue.17, pp.2123-2129, 2002.
DOI : 10.1001/jama.288.17.2123